Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jul 18, 2018
Document Date
Jul 16, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
FORMELA JEAN FRANCOIS